The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3

Background. Evaluate the effect of the miRNA-106a/20b on the efficacy of DCs pulsed with GSCs in activating GSC-specific T cell responses. Methods. We cultured GSCs and prepared GSC antigen lysates by apoptosis. Then, immature DCs were pulsed with GSC antigen lysates in vitro. STAT3 levels in DCs we...

Full description

Saved in:
Bibliographic Details
Main Authors: Hui Zhou, Chengmei Sun, Cong Li, Shiting Hua, Feng Li, Ruichun Li, Dongpeng Cai, Yuxi Zou, Yingqian Cai, Xiaodan Jiang
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/9721028
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832551658561732608
author Hui Zhou
Chengmei Sun
Cong Li
Shiting Hua
Feng Li
Ruichun Li
Dongpeng Cai
Yuxi Zou
Yingqian Cai
Xiaodan Jiang
author_facet Hui Zhou
Chengmei Sun
Cong Li
Shiting Hua
Feng Li
Ruichun Li
Dongpeng Cai
Yuxi Zou
Yingqian Cai
Xiaodan Jiang
author_sort Hui Zhou
collection DOAJ
description Background. Evaluate the effect of the miRNA-106a/20b on the efficacy of DCs pulsed with GSCs in activating GSC-specific T cell responses. Methods. We cultured GSCs and prepared GSC antigen lysates by apoptosis. Then, immature DCs were pulsed with GSC antigen lysates in vitro. STAT3 levels in DCs were assessed by Western blotting, and the expression of CD80, CD86, and MHC-II was tested by fluorescence-activated cell sorting. The production and secretion of the cytokines IL-6, IL-12, TNF-α, and IL-10 in DCs induced by GSCs were determined by enzyme-linked immunosorbent assay. Finally, the cytotoxic functions of T cells stimulated by GSC-DC fusion cells transfected with a miR-106a/20b mimic in vitro and the antitumour activity in vivo were detected. Results. We found that the levels of miR-106a/20b were downregulated, but the expression of STAT3 was significantly upregulated. Simultaneously, the inhibition of STAT3 in the fusion cells by STAT3-specific siRNA caused significant upregulation of the expression of CD80, CD86, and MHC-II, and the secretion of the cytokines IL-6 and IL-12 was substantially increased, IL-10 was markedly decreased. These findings revealed that STAT3 is an important regulator of DC maturation. Furthermore, the interactional binding sites between the 3′-untranslated region (3′-UTR) of STAT3 mRNA and miR-106a/20b were predicted by bioinformatics and verified by a dual-luciferase assay. Moreover, the reduction in STAT3 levels in GSC-DCs enhanced the generation of CD8+ T cells and reduced the generation of Foxp3+ regulatory T cells. Meanwhile, the secretion of the T cell cytokine IFN-γ was significantly increased. Further research showed that DCs after miR-106a/20b-mimics transfection could promote the inhibition of GSC proliferation by T cells in vitro and suppress tumour growth in vivo. Conclusions. This study indicted that the miR-106a/20b activation could be one of the important molecular mechanisms leading to enhance antitumour immune responses of GSC-mediated DCs, which downregulated the expression of STAT3 to alleviate its the inhibitory effect.
format Article
id doaj-art-3413c4ec5a454ab0abf3ad2320059f69
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-3413c4ec5a454ab0abf3ad2320059f692025-02-03T06:00:56ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/9721028The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3Hui Zhou0Chengmei Sun1Cong Li2Shiting Hua3Feng Li4Ruichun Li5Dongpeng Cai6Yuxi Zou7Yingqian Cai8Xiaodan Jiang9Neurosurgery CenterNeurosurgery CenterNeurosurgery CenterNeurosurgery CenterNeurosurgery CenterDepartment of NeurosurgeryDepartment of NeurosurgeryNeurosurgery CenterNeurosurgery CenterNeurosurgery CenterBackground. Evaluate the effect of the miRNA-106a/20b on the efficacy of DCs pulsed with GSCs in activating GSC-specific T cell responses. Methods. We cultured GSCs and prepared GSC antigen lysates by apoptosis. Then, immature DCs were pulsed with GSC antigen lysates in vitro. STAT3 levels in DCs were assessed by Western blotting, and the expression of CD80, CD86, and MHC-II was tested by fluorescence-activated cell sorting. The production and secretion of the cytokines IL-6, IL-12, TNF-α, and IL-10 in DCs induced by GSCs were determined by enzyme-linked immunosorbent assay. Finally, the cytotoxic functions of T cells stimulated by GSC-DC fusion cells transfected with a miR-106a/20b mimic in vitro and the antitumour activity in vivo were detected. Results. We found that the levels of miR-106a/20b were downregulated, but the expression of STAT3 was significantly upregulated. Simultaneously, the inhibition of STAT3 in the fusion cells by STAT3-specific siRNA caused significant upregulation of the expression of CD80, CD86, and MHC-II, and the secretion of the cytokines IL-6 and IL-12 was substantially increased, IL-10 was markedly decreased. These findings revealed that STAT3 is an important regulator of DC maturation. Furthermore, the interactional binding sites between the 3′-untranslated region (3′-UTR) of STAT3 mRNA and miR-106a/20b were predicted by bioinformatics and verified by a dual-luciferase assay. Moreover, the reduction in STAT3 levels in GSC-DCs enhanced the generation of CD8+ T cells and reduced the generation of Foxp3+ regulatory T cells. Meanwhile, the secretion of the T cell cytokine IFN-γ was significantly increased. Further research showed that DCs after miR-106a/20b-mimics transfection could promote the inhibition of GSC proliferation by T cells in vitro and suppress tumour growth in vivo. Conclusions. This study indicted that the miR-106a/20b activation could be one of the important molecular mechanisms leading to enhance antitumour immune responses of GSC-mediated DCs, which downregulated the expression of STAT3 to alleviate its the inhibitory effect.http://dx.doi.org/10.1155/2022/9721028
spellingShingle Hui Zhou
Chengmei Sun
Cong Li
Shiting Hua
Feng Li
Ruichun Li
Dongpeng Cai
Yuxi Zou
Yingqian Cai
Xiaodan Jiang
The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3
Journal of Immunology Research
title The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3
title_full The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3
title_fullStr The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3
title_full_unstemmed The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3
title_short The MicroRNA-106a/20b Strongly Enhances the Antitumour Immune Responses of Dendritic Cells Pulsed with Glioma Stem Cells by Targeting STAT3
title_sort microrna 106a 20b strongly enhances the antitumour immune responses of dendritic cells pulsed with glioma stem cells by targeting stat3
url http://dx.doi.org/10.1155/2022/9721028
work_keys_str_mv AT huizhou themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT chengmeisun themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT congli themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT shitinghua themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT fengli themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT ruichunli themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT dongpengcai themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT yuxizou themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT yingqiancai themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT xiaodanjiang themicrorna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT huizhou microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT chengmeisun microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT congli microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT shitinghua microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT fengli microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT ruichunli microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT dongpengcai microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT yuxizou microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT yingqiancai microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3
AT xiaodanjiang microrna106a20bstronglyenhancestheantitumourimmuneresponsesofdendriticcellspulsedwithgliomastemcellsbytargetingstat3